CSIMarket
 




Cytokinetics Incorporated  (CYTK)
Other Ticker:  
 
 



CYTK Price to Earnings Ratio (Sep 30 2023) (Jun 30 2023) (Mar 31 2023) (Dec 31 2022) (Sep 30 2022)
Diluted EPS 12 Trailing Months III. Quarter II. Quarter I. Quarter IV. Quarter III. Quarter
PE (TTM) Ratio current            -            -            -            -            -
Diluted EPS TTM Y / Y Change 68.81 % 112.48 % 36.5 % 43.64 % 2.38 %
Diluted EPS Y / Y Change -11.18 % 482.61 % 31.43 % 249.81 % 60 %
Stock performance to date 73.57 % -11.7 % -12.68 % -1.19 % 6.2 %

Price to earnings ratio Comment
Cytokinetics Incorporated's recorded net loss in trailing twelve months.

Within Healthcare sector Cytokinetics Incorporated has the lowest Price to earnings ratio.

What is Price to Earnings Ratio?
What is Cytokinetics Incorporated Market Share?

Price to earnings ratio Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com